This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bailey, L. R. Articles by Parl, F. F. Search for Related Content PubMed PubMed Citation Articles by Bailey, L. R. Articles by Parl, F. F.

Breast Cancer and CYPIA1, GSTM1, and GSTT1 Polymorphisms: Evidence of a Lack of Association in Caucasians and African Americans¹

Departments of Pathology [L. R. B., N. R., C. S. V., C. J. Y., F. F. P.] and Preventive Medicine [W. D. D.], Vanderbilt University, Nashville, Tennessee 37232

Genetically based differences in carcinogen metabolism have been related to polymorphisms of the cytochrome P450IA1 gene (CYPIA1) and the null genotypes of glutathione S-transferase classes mu and theta (GSTM1 and GSTT1). By PCR we examined the genotypes of CYPIA1, GSTM1, and GSTT1 in relation to breast cancer risk in Caucasian and African-American women. The study included 164 Caucasian and 59 African-American women with primary invasive breast cancer and age-matched female controls. Enzyme polymorphisms included in this study were the null deletions of GSTM1 and GSTT1 and the m1 (MspI), m2 (codon 462: isoleucinevaline), m3 (MspI-AA), and m4 (codon 461: threonineasparagine) polymorphisms of CYPIA1. Contrary to previous reports by other investigators, none of the enzyme genotypes, individually or combined, appear to associate with an increased risk for breast cancer in Caucasian or African-American women. We also report that the recently described m4 allele occurs at a lower frequency in African-Americans than Caucasians and is not linked with breast cancer in either race. Thus, it is unlikely that polymorphisms of GSTM1, GSTT1, or CYPIA1 represent susceptibility factors for breast cancer in Caucasians or African-Americans.

¹ Supported in part by United States Army Breast Cancer Training Grant DAMD-17-94-J4024 (to L. R. B. and C. J. Y.), USPHS Grant HD-07043-22 (to C. S. V.), and National Cancer Institute Grant CA50468-06 (to W. D. D.)

² To whom requests for reprints should be addressed, at Department of Pathology, TVC 4918, Vanderbilt University, Nashville, TN 37232.

Received 6/ 2/97. Accepted 10/28/97.

This article has been cited by other articles:

				S. L. Deming, W. Zheng, W.-H. Xu, Q. Cai, Z. Ruan, Y.-B. Xiang, and X.-O. Shu UGT1A1 Genetic Polymorphisms, Endogenous Estrogen Exposure, Soy Food Intake, and Endometrial Cancer Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 563 - 570. [Abstract] [Full Text] [PDF]

				A. Rossini, D.C.M. Rapozo, S.C. Soares Lima, D.P. Guimaraes, M.A. Ferreira, R. Teixeira, C.D.P. Kruel, S.G.S. Barros, N.A. Andreollo, R. Acatauassu, et al. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population Carcinogenesis, December 1, 2007; 28(12): 2537 - 2542. [Abstract] [Full Text] [PDF]

				T. R. Rebbeck, A. B. Troxel, A. H. Walker, S. Panossian, S. Gallagher, E. G. Shatalova, R. Blanchard, S. Norman, G. Bunin, A. DeMichele, et al. Pairwise Combinations of Estrogen Metabolism Genotypes in Postmenopausal Breast Cancer Etiology Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 444 - 450. [Abstract] [Full Text] [PDF]

				P. S. Crooke, M. D. Ritchie, D. L. Hachey, S. Dawling, N. Roodi, and F. F. Parl Estrogens, enzyme variants, and breast cancer: a risk model. Cancer Epidemiol. Biomarkers Prev., September 1, 2006; 15(9): 1620 - 1629. [Abstract] [Full Text] [PDF]

				A. E. Cribb, M. J. Knight, D. Dryer, J. Guernsey, K. Hender, M. Tesch, and T. M. Saleh Role of polymorphic human cytochrome p450 enzymes in estrone oxidation. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 551 - 558. [Abstract] [Full Text] [PDF]

				Y. Shen, D.-K. Li, J. Wu, Z. Zhang, and E. Gao Joint Effects of the CYP1A1 MspI, ER{alpha} PvuII, and ER{alpha} XbaI Polymorphisms on the Risk of Breast Cancer: Results from a Population-Based Case-Control Study in Shanghai, China. Cancer Epidemiol. Biomarkers Prev., February 1, 2006; 15(2): 342 - 347. [Abstract] [Full Text] [PDF]

				Y.-L. Zheng, C. A. Loffredo, A. J. Alberg, Z. Yu, R. T. Jones, D. Perlmutter, L. Enewold, M. J. Krasna, R. Yung, P. G. Shields, et al. Less Efficient G2-M Checkpoint Is Associated with an Increased Risk of Lung Cancer in African Americans Cancer Res., October 15, 2005; 65(20): 9566 - 9573. [Abstract] [Full Text] [PDF]

				L. F. Masson, L. Sharp, S. C. Cotton, and J. Little Cytochrome P-450 1A1 Gene Polymorphisms and Risk of Breast Cancer: A HuGE Review Am. J. Epidemiol., May 15, 2005; 161(10): 901 - 915. [Abstract] [Full Text] [PDF]

				J. A. Doherty, N. S. Weiss, R. J. Freeman, D. A. Dightman, P. J. Thornton, J. R. Houck, L. F. Voigt, M. A. Rossing, S. M. Schwartz, and C. Chen Genetic Factors in Catechol Estrogen Metabolism in Relation to the Risk of Endometrial Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 357 - 366. [Abstract] [Full Text] [PDF]

				Y. Zhang, J. P. Wise, T. R. Holford, H. Xie, P. Boyle, S. H. Zahm, J. Rusiecki, K. Zou, B. Zhang, Y. Zhu, et al. Serum Polychlorinated Biphenyls, Cytochrome P-450 1A1 Polymorphisms, and Risk of Breast Cancer in Connecticut Women Am. J. Epidemiol., December 15, 2004; 160(12): 1177 - 1183. [Abstract] [Full Text] [PDF]

				F. D. Vogl, E. Taioli, C. Maugard, W. Zheng, L. F. Ribeiro Pinto, C. Ambrosone, F. F. Parl, V. Nedelcheva-Kristensen, T. R. Rebbeck, P. Brennan, et al. Glutathione S-transferases M1, T1, and P1 and Breast Cancer: A Pooled Analysis Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1473 - 1479. [Abstract] [Full Text] [PDF]

				N. Roodi, W. D. Dupont, J. H. Moore, and F. F. Parl Association of Homozygous Wild-Type Glutathione S-Transferase M1 Genotype with Increased Breast Cancer Risk Cancer Res., February 15, 2004; 64(4): 1233 - 1236. [Abstract] [Full Text] [PDF]

				K. M. Egan, Q. Cai, X.-O. Shu, F. Jin, T.-L. Zhu, Q. Dai, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in GSTM1, GSTP1, and GSTT1 and the Risk for Breast Cancer: Results from the Shanghai Breast Cancer Study and Meta-Analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 197 - 204. [Abstract] [Full Text] [PDF]

				A. R. Kallianpur, L. D. Hall, M. Yadav, B. W. Christman, R. S. Dittus, J. L. Haines, F. F. Parl, and M. L. Summar Increased Prevalence of the HFE C282Y Hemochromatosis Allele in Women with Breast Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 205 - 212. [Abstract] [Full Text] [PDF]

				J. Stevens Racial Meanings and Scientific Methods: Changing Policies for NIH-Sponsored Publications Reporting Human Variation Journal of Health Politics Policy and Law, December 1, 2003; 28(6): 1033 - 1088. [Abstract] [PDF]

				F. Laden, N. Ishibe, S. E. Hankinson, M. S. Wolff, D. M. Gertig, D. J. Hunter, and K. T. Kelsey Polychlorinated Biphenyls, Cytochrome P450 1A1, and Breast Cancer Risk in the Nurses' Health Study Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1560 - 1565. [Abstract] [Full Text] [PDF]

				M M de Jong, I M Nolte, G J te Meerman, W T A van der Graaf, J C Oosterwijk, J H Kleibeuker, M Schaapveld, and E G E de Vries Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility J. Med. Genet., April 1, 2002; 39(4): 225 - 242. [Abstract] [Full Text] [PDF]

				P. F. Firozi, M. L. Bondy, A. A. Sahin, P. Chang, F. Lukmanji, E. S. Singletary, M. M. Hassan, and D. Li Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer Carcinogenesis, February 1, 2002; 23(2): 301 - 306. [Abstract] [Full Text] [PDF]

				S. Garte, L. Gaspari, A.-K. Alexandrie, C. Ambrosone, H. Autrup, J. L. Autrup, H. Baranova, L. Bathum, S. Benhamou, P. Boffetta, et al. Metabolic Gene Polymorphism Frequencies in Control Populations Cancer Epidemiol. Biomarkers Prev., December 1, 2001; 10(12): 1239 - 1248. [Abstract] [Full Text] [PDF]

				V. M. Basham, P. D.P. Pharoah, Catherine.S. Healey, R. N. Luben, N. E. Day, D. F. Easton, B. A.J. Ponder, and A. M. Dunning Polymorphisms in CYP1A1 and smoking: no association with breast cancer risk Carcinogenesis, November 1, 2001; 22(11): 1797 - 1800. [Abstract] [Full Text] [PDF]

				K. Mitrunen, N. Jourenkova, V. Kataja, M. Eskelinen, V.-M. Kosma, S. Benhamou, H. Vainio, M. Uusitupa, and A. Hirvonen Glutathione S-Transferase M1, M3, P1, and T1 Genetic Polymorphisms and Susceptibility to Breast Cancer Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 229 - 236. [Abstract] [Full Text]

				T. R Holford, T. Zheng, S. T Mayne, S. H Zahm, J. D Tessari, and P. Boyle Joint effects of nine polychlorinated biphenyl (PCB) congeners on breast cancer risk Int. J. Epidemiol., December 1, 2000; 29(6): 975 - 982. [Abstract] [Full Text] [PDF]

				A. Rundle, D. Tang, J. Zhou, S. Cho, and F. Perera The Association between Glutathione S-Transferase M1 Genotype and Polycyclic Aromatic Hydrocarbon-DNA Adducts in Breast Tissue Cancer Epidemiol. Biomarkers Prev., October 1, 2000; 9(10): 1079 - 1085. [Abstract] [Full Text]

				D. J. Peel, A. Ziogas, E. A. Fox, M. Gildea, B. Laham, E. Clements, R. D. Kolodner, and H. Anton-Culver Characterization of Hereditary Nonpolyposis Colorectal Cancer Families From a Population-Based Series of Cases J Natl Cancer Inst, September 20, 2000; 92(18): 1517 - 1522. [Abstract] [Full Text] [PDF]

				J. D. Yager Chapter 3: Endogenous Estrogens as Carcinogens Through Metabolic Activation J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 67 - 73. [Abstract] [Full Text] [PDF]

				P. A. Thompson and C. Ambrosone Chapter 7: Molecular Epidemiology of Genetic Polymorphisms in Estrogen Metabolizing Enzymes in Human Breast Cancer J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 125 - 134. [Abstract] [Full Text] [PDF]

				W. Tan, N. Song, G.-Q. Wang, Q. Liu, H.-J. Tang, F. F. Kadlubar, and D.-X. Lin Impact of Genetic Polymorphisms in Cytochrome P450 2E1 and Glutathione S-Transferases M1, T1, and P1 on Susceptibility to Esophageal Cancer among High-Risk Individuals in China Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 551 - 556. [Abstract] [Full Text]

				R. Millikan, G. Pittman, C.-K. Tse, D. A. Savitz, B. Newman, and D. Bell Glutathione S-Transferases M1, T1, and P1 and Breast Cancer Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 567 - 573. [Abstract] [Full Text]

				C. Guillemette, R. C. Millikan, B. Newman, and D. E. Housman Genetic Polymorphisms in Uridine Diphospho-Glucuronosyltransferase 1A1 and Association with Breast Cancer among African Americans Cancer Res., February 1, 2000; 60(4): 950 - 956. [Abstract] [Full Text]

				H. Bartsch, U. Nair, A. Risch, M. Rojas, H. Wikman, and K. Alexandrov Genetic Polymorphism of CYP Genes, Alone or in Combination, as a Risk Modifier of Tobacco-related Cancers Cancer Epidemiol. Biomarkers Prev., January 1, 2000; 9(1): 3 - 28. [Abstract] [Full Text]

				M. Garcia-Closas, K. T. Kelsey, S. E. Hankinson, D. Spiegelman, K. Springer, W. C. Willett, F. E. Speizer, and D. J. Hunter Glutathione S-Transferase Mu and Theta Polymorphisms and Breast Cancer Susceptibility J Natl Cancer Inst, November 17, 1999; 91(22): 1960 - 1964. [Abstract] [Full Text] [PDF]

				A. M. Dunning, C. S. Healey, P. D. P. Pharoah, M. D. Teare, B. A. J. Ponder, and D. F. Easton A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., October 1, 1999; 8(10): 843 - 854. [Abstract] [Full Text]

				C.-S. Huang, H.-D. Chern, K.-J. Chang, C.-W. Cheng, S.-M. Hsu, and C.-Y. Shen Breast Cancer Risk Associated with Genotype Polymorphism of the Estrogen-metabolizing Genes CYP17, CYP1A1, and COMT: A Multigenic Study on Cancer Susceptibility Cancer Res., October 1, 1999; 59(19): 4870 - 4875. [Abstract] [Full Text] [PDF]

				S. Longuemaux, C. Delomenie, C. Gallou, A. Mejean, M. Vincent-Viry, R. Bouvier, D. Droz, R. Krishnamoorthy, M.-M. Galteau, C. Junien, et al. Candidate Genetic Modifiers of Individual Susceptibility to Renal Cell Carcinoma: A Study of Polymorphic Human Xenobiotic-metabolizing Enzymes Cancer Res., June 1, 1999; 59(12): 2903 - 2908. [Abstract] [Full Text] [PDF]

				C. B. Ambrosone, B. F. Coles, J. L. Freudenheim, and P. G. Shields Glutathione-S-transferase (GSTM1) Genetic Polymorphisms Do Not Affect Human Breast Cancer Risk, Regardless of Dietary Antioxidants J. Nutr., February 1, 1999; 129(2): 565 - 565. [Abstract] [Full Text] [PDF]

				K. B. Moysich, P. G. Shields, J. L. Freudenheim, E. F. Schisterman, J. E. Vena, P. Kostyniak, H. Greizerstein, J. R. Marshall, S. Graham, and C. B. Ambrosone Polychlorinated Biphenyls, Cytochrome P4501A1 Polymorphism, and Postmenopausal Breast Cancer Risk Cancer Epidemiol. Biomarkers Prev., January 1, 1999; 8(1): 41 - 44. [Abstract] [Full Text]